# A Study of the KIO-201 (Ocular Bandage Gel) for Improving Persistent Corneal Epithelial Defects

> **NCT05436288** · PHASE2 · COMPLETED · sponsor: **Kiora Pharmaceuticals, Inc.** · enrollment: 10 (actual)

## Conditions studied

- Persistent Corneal Epithelial Defect

## Interventions

- **DRUG:** KIO-201, a Crosslinked Thiolated Carboxymethyl Hyaluronic Acid 0.75% (CMHA-S)

## Key facts

- **NCT ID:** NCT05436288
- **Lead sponsor:** Kiora Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-07-01
- **Primary completion:** 2022-12-22
- **Final completion:** 2023-01-22
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2024-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05436288

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05436288, "A Study of the KIO-201 (Ocular Bandage Gel) for Improving Persistent Corneal Epithelial Defects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05436288. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*